EMCrit FOAM Feed

EMCrit FOAM Feed

By Scott D. Weingart, MD FCCMScienceMedicineHealth & Fitness
Download on the App Store
  • Favorites

    1,064

    Followers

  • Latest release

    7 days ago

  • Typical duration

    29 min

    per episode

  • If it hooks

    52%

    finish an episode

Based on Podcast App listening data

All EMCrit FOAM Feed episodes

  • A Wee Bit More on Massive Hemoptysis


    George Kovacs left a great comment on the hemoptysis post:

    Great discussion.  Unfortunately with these cases getting the tube is THE major problem before we consider any bronchoscopic intervention. Here are my pearls based on experience and cadaveric simulations:

    * Call for help: Patients with massive pulmonary hemorrhage die. Respect hemoptysis especially related to tumors or scenarios where there is an erosion into a vessel. They're ok until they're not and then its often too late,
    * Send someone to the chart/x-ray to get info as to which side the pathology is on
    * Raising the bed will help allow you to lift the epiglottis out of the pool of blood and see it more easily.
    * Do the Ducanto thing... SALAD
    * Hope that the disease is on the left. If you know this use a bougie and 1/4 turn to the right once (if) you feel clicks and place gently until holdup then go ahead with a BFT. As per the study quoted in this piece we have been able to consistently cannulate the bronchus of choice using a bougie in cadavers.
    * If you are not sure of the side they are bleeding from then we would suggest a poor man's isolation technique using a 7.0 ETT and intubating the RM bronchus either with or without a bougie. The left side can then be accessed with a bougie again by a 1/4 turn to the left once in the trachea and advancing until gentle hold up at ~30 cm and placing a second 7.0 ETT. Yes I know that a bronch won't like these tubes but otherwise there is no opportunity for subsequent therapy as the patient drowns. It's an awful death. You can block the offending side with a foley.
    * If bleeding is too much and SALAD etc approach fails... these patients die. One device that will be returning to the market developed here in Halifax is the lightwand and its the only device out there that will consistently be successful in a soiled airway.... IF YOU HAVE IT AND IF YOU HAVE EXPERIENCE WITH IT which most don't. It has saved my ass numerous times.
    * If you can't see from above then FONA is indicated use a small ETT 5.0 and push it too hilt will usually go to RM bronchus. You will either be able to oxygenate or divert blood so now you can put a second tube in if necessary from above. Used a 5.0 ETT because takes up less real estate for second tube to pass from above.
    * When your consultant comes down and complains about the size of tubes that are in place resist telling them to fuck off.

    Now on to the Wee...
    9 min
  • EMCrit Wee – An Amazing (Wearable) Cric Trainer from Laura Duggan and the AirwayCollaboration Folks

    So my friend Laura Duggan has been engaged in a multi-prong project to save lives through the dissemination of surgical airway information. We've previously discussed the airway app to collect data on front-of-neck-access. Now she is releasing a cric model that blows the old ones I used to recommend out of the water. You want one of these models... You want one to practice the moves of surgical airway at least once a month. Laura is not charging for this model, she is releasing it into the wild as FOAM. You'll have to get it 3d printed yourself--we'll tell you how

    Instructions for Printing
    3D Cric Trainer Instructions
    Where to Print
    3Dsmith in Canada
    3Dsmith.ca
    Chris and Steve are brothers who own their small company
    They are awesome

    get  formlabs standard resin as the material and it will resist scalpels beautifully!
    Shapeways for the USA
    shapeways.com

    Got my model

    Went with the strong & flexible plastic for $21.78

    feel is rough but function is great
    Buy Kevlar if you plan on wearing this cric trainer
    [easyazon_image align="none" height="160" identifier="B00QL4M1PG" locale="US" src="http://emcrit.org/wp-content/uploads/2017/07/411NpNhDT2L.SL160.jpg" tag="emcrit-20" width="160"]

    [easyazon_link identifier="B00QL4M1PG" locale="US" tag="emcrit-20"]CRL Cut Protection Kevlar® Neck Protector 99995[/easyazon_link]
    The Model (Send this to your 3D Printer)

    * Full Resolution Plans

    Go to Airway Collaboration Site

    * www.airwaycollaboration.org/

    Matt Mac Partlin Has a Cardboard Model
    See the ETM/Vortex Version by Andy Buck (with a cool printable neck)
    Disclaimer
    If you decide to wear or have colleagues wear this, it is at your own risk. It is inherently dangerous to come at anyone with a scalpel
    Now on to the Wee...
    9 min
  • Podcast 204 – The Nurse-Led Code with Joe Bellezzo


    I am joined again by my good friend, Joe Bellezzo, to discuss the nurse-led code. I've been doing this at my two shops for about a decade. Joe, along with his partners-in-crime Zack Shinar & Chris Ho, have set up a beautiful process for nurse led code management at their hospital, Sharp Memorial in San Diego.
    Stuff Mentioned in the Podcast

    * Here is the tactical-approach podcast from EDECMO.org
    * EMCrit Intra-Arrest Management Lecture
    * Podcast 191 - Cardiac Arrest Update

    The SBM Nurse Leader Responsibilities

    * Call for Epi q 5 minutes. Once A-line is in, decide on epi based on art line DBP<40
    * Pre-announce the rhythm check 30 seconds beforehand
    * Call for the rhythm check
    * Act as the receiver for all requests from the team and assign people to get these tasks done
    * Spur doc-leader based on timing of code and any thoughts that occur while having a non-task focused view of the code

    Update:
    CANLEAD Study on the Nurse-Led Code in simulation
    Now on to the Podcast...
    20 min
  • Podcast 203 – New Reversals for New Anticoagulants with Nadia Awad


    This stuff is not sexy and frankly, it hurts my head. That is all the more reason to do a show on the new landscape of NOAC reversal. We must pursue rather than avoid the subjects we are weak on. But I needed someone far smarter than myself--I needed a EM PharmD. Nobody better to speak about this topic than Nadia Awad. Nadia is associate editor of the Emergency Medicine PharmD Blog. She is an Emergency Medicine Pharmacist at the Robert Wood Johnson University Hospital in New Jersey.
    Laboratory Parameters for Monitoring Target-Specific Oral Anticoagulants

    * Hawes EM et al. J Thromb Haemost 2013; 11:1493-1502.
    * Cuker A et al. J Am Coll Cardiol 2014; 64:1128-1139.
    * Favaloro EJ et al. Semin Thromb Hemost 2015; 41:208-227.
    * Samuelson BT et al. Blood Reviews 2017; 31:77-84.

    Interim Analysis of Idarucizumab: REVERSE-AD

    * Pollack CV et al. N Engl J Med 2015; 373:511-20.

    Clinical Experiences Reported in Literature with Idarucizumab Following Approval by FDA

    * Reviewed on Emergency Medicine PharmD

    Fantastic Review on Idarucizumab

    * Miller et al.

    Use of Extracorporeal Measures to Expedite Elimination of Dabigatran in the Setting of Life-Threatening Bleeding

    * Awad NI et al. J Med Toxicol 2015; 11:85-95.

    Andexanet Alfa

    * Siegal DM et al. N Engl J Med 2015; 373:2413-2424.
    * Connolly SJ et al. N Engl J Med 2016; 375:1131-1141.

    Low-Dose FEIBA for ICH Induced by Factor Xa Inhibitors
    Mao G et al. JEM 2016 [Epub ahead of print].
    Aripazine (PER977) AKA Ciraparantag

    * Ansell JE et al. N Engl J Med 2014; 22:2141-2142.
    * Ansell JE et al. Thromb Haemost 2017; 117:238-245.

    Recommendations for Reversal of ICH Induced by Antithrombotics from Neurocritical Care Society

    * Frontera JA et al. Neurocrit Care 2016; 24:6-46.

    Excellent reviews on Idarucizumab

    * Ann Emerg Med 2017;69(5):554
    * EM Lit of Note

    Dosing
    Monoclonal antibody
    works within minutes
    Thrombin time and ECT are best monitoring, aPTT if stone-cold normal prob. rules out Dabi
    Package comes with 2 vials
    2.5 gm each
    5 gms is the initial dose
    Give each over 5 minutes
    Spike and hang vial
    give 2nd vial with 15 minutes of first (no reason not to give immediately)
    $4200 for both vials at Janus General
    Dabi lasts 12 hours in normal patients, and antidote lasts same ostensibly
    Kcentra Studies

    * RCT of Kcentra (Circulation 2013;128:1234)

    28 min
  • EMCrit 201 – Deeper on Vasopressors and Athos 3 with Mink Chawla


    In Ep. 138, we discussed the basics of vasopressor and inotrope use. During that podcast, I promised we would go more in-depth in subsequent episodes--this is one of those that will fulfill that promise. Angiotensin II is a new (old) player on the field. To discuss this topic and more on vasopressors, I asked Dr. Mink Chawla to join me on the podcast.
    Conflict of Interest Disclaimer
    Dr. Chawla is the CMO of La Jolla Pharmaceuticals, the manufacturer of Angiotensin II
    Bio for Dr. Chawla
    Dr. Chawla is Chief Medical Officer of La Jolla Pharmaceuticals. Dr. Chawla was an Professor of Medicine at the George Washington University, where he had dual appointments in the Department of Anesthesiology and Critical Care Medicine and in the Department of Medicine, Division of Renal Diseases and Hypertension. Dr. Chawla was also the Chief of the Division of Intensive Care Medicine at the Washington D.C. Veterans Affairs Medical Center. During his tenure at George Washington, Dr. Chawla was the designer and lead investigator of a pilot study called the ATHOS (Angiotensin II for the Treatment of High Output Shock) trial.  Dr. Chawla was an active investigator in shock, inflammation and extracorporeal therapies, including: continuous renal replacement therapy, dialysis and albumin dialysis. Dr. Chawla is also the author of over 100 peer-reviewed publications and an Associate Editor for the Clinical Journal of the American Society of Nephrology.
    Dr. Chawla's Maryland CC Project Lecture

    * Link to the Maryland CC Project Video
    * Link to the Maryland CC Project Shownotes

    Article Mentioned Regarding IntraOp Hypotension

    * Walsh & Sessler et al.
    * Also Check out: (Intens Care Med 2018;44:811)

    Now on to the Podcast...
    Angio II Papers

    * The use of angiotensin II in distributive shock-
    * Angiotensin II for the Treatment of Vasodilatory Shock - NEJM - 2017-(Athos 3)
    * Angiotensin-II- More Than Just Another Vasoconstrictor to Treat Septic Shock–Induced Hypotension
    * ATHOS-3 protocol & editorial, CCR_Mar_17_text[1]
    * ATHOS-3_appendix
    * Chawla-ATHOS-Crit Care-2014-(Athos 1)
    * Clinical_Experience_With_Angiotensin_II

    Links of Interest

    * Vasopressor Basics Show
    * PulmCrit's Voodoo
    *
    29 min
  • EMCrit Podcast 199 – Management of Massive Hemoptysis with Oren Friedman

    Today, I am joined by my buddy and pulmonary-critical care stud, Oren Friedman, to discuss the management of Massive Hemoptysis
    See More from Oren

    * Clot Management of Massive and SubMassive PE
    * Hemodynamic Management of PE

    Some Basics on Massive Hemoptysis

    * LitFL
    * First10 EM
    * Review by Sakkour on Massive Hemoptysis
    * IBCC chapter  Severe hemoptysis
    * A Wee Bit More on Massive Hemoptysis


    Intubate Big
    Localize
    C-XR, chart review, and initial bronch. Remember Oren's tip: if you get in there and can't find any bleeding, temporarily disconnect the vent
    Is it Amenable to Bronch Treatment?
    If not, Block; preferably at the segmental level
    Use a bronchial blocker, not a double lumen tube
    Uni Blocker

    EZ Blocker

    A poor 2nd choice is mainstem intubation
    Bougie for selective lung
    Then Get a CTA of the Chest
    make sure to order a delayed phase to see the systemic circulation as well
    Then go to IR for Bronchial Artery Embolization
    95% of the lesions will arrise from the bronchial circulation. The ones that don't are PE, Pulmonary Art Catheter mishaps, and AVMs of the Pulmonary arterial circulation.
    If that fails, Surgery or ECMO
    Updates

    * Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial. Chest. 2018 Oct 12. pii: S0012-3692(18)32572-8. doi: 10.1016/j.chest.2018.09.026.
    * Great Review Article from CHEST

    Now, On to the Podcast...
    25 min
  • Podcast 198 – Insulin Pumps and Such with Josh Miller, MD


    Today, we discuss the topic of insulin pumps. Heralded as a huge advance in the management of insulin-dependent diabetes mellitus (IDDM), they also bring a bit more complexity to the mix. To sort through this confusion, I brought my friend Josh Miller (@glucosedoc) on to the show to discuss.
    Josh Miller, MD
    Dr. Joshua D. Miller is the Medical Director of Diabetes Care for Stony Brook Medicine and an Assistant Professor of Endocrinology & Metabolism in the Department of Medicine. He is dual board-certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.  Dr. Miller has vast experience helping people with diabetes to conquer the challenges of living with the disease; he has been living with type 1 diabetes for over twenty years. He is an expert in insulin pump and glucose sensor management as well as the transition of care to adult endocrinology for young adults with diabetes.
    What we Covered
    Tell Us About Insulin Pumps

    * Settings (Basal, Bolus)
    * What can go wrong
    * How do we know if it is functioning
    * How to turn it Off
    * Site Infection--is this even an issue?
    * More on Insulin Pumps

    What do We do If Pt with PUMP has DKA?

    * Leave It on or
    * Supplement or
    * Adjust Settings or
    * Turn it off--if so how to take pt settings into account

    Basal Insulin in the Critically Ill

    * How much and how
    * Insulin Drip
    * Is Lantus Safe-how much and when

    Euglycemic DKA

    * what agents (SGLT2)
    * how to manage
    * See also RebelEM

    Hypoglycemia with a Pump
    from Josh: Hypoglycemia in a patient with diabetes on pump is multifactorial. If the hypoglycemia is so severe as to warrant admission, I would suspend or remove the pump. The patient should undoubtedly be assessed for insulin pump competency and diabetes self management skills. Acutely, patients should know how to temp basal or suspend the pump. Rarely would we treat through the insulin with dextrose and continue 100% basal delivery. If the patient is altered in any way, the pump should be suspended (by someone knowledgeable about pump function) or removed and an alternative SQ insulin regimen should immediately be pursued. The risk of course is forgetting the depot regimen and, once hypoglycemia resolves, causing ketosis.

    Take home point: hypoglycemia on pump = call endocrine immediately.

    Additional Info
    Br. J. Anaesth.-2016-Partridge-18-26

    Now on to the Show...
    24 min
  • Ketamine ……. then Rocuronium, DSI & The Timing Principle


    So Josh's post yesterday (Rocketamine vs. keturonium for rapid sequence intubation) sparked much controversy and comment. I wanted to wade into the conflict, hence this wee.
    Rocuronium Administration-Prior to Sedative
    Administering roc as first drug is a variation of the timing principle demonstrated in a bunch of studies RCTs, here are 4 of them:

    * http://www.ncbi.nlm.nih.gov/pubmed/9195356
    * http://www.ncbi.nlm.nih.gov/pubmed/9585312
    * http://www.ncbi.nlm.nih.gov/pubmed/7923516
    * https://www.ncbi.nlm.nih.gov/pubmed/21547177

    The most effective way to administer the med is actually to administer the sedative 15 sec after the roc, but most do not go that far. An easier to justify method is:

    * Roc
    * Induction agent
    * Flush

    This is my method for etomidate or propofol. For ketamine, I prefer DSI-type administration.
    Update

    * Driver et al. did an RCT https://doi.org/10.1111/acem.13723

    Listen to the Wee to Hear my Thoughts...
    11 min